By Admin 
After the announcement of US President Donald Trump, there was a major decline in shares of Indian pharmaceutical companies, in which he said that he was going to sign an order that reduced the prices of American drugs by about 30 to 80 per cent. After this, the shares of the country’s big pharmaceutical company Sun Pharma fell to 1,623.60 in early trade by Monday i.e. May 12.
Along with this, shares of pharmaceutical companies like Astrazenica, Lupine, Glenmark and Arabido Pharma also saw a decline of 3 percent. & Nbsp;
Trump wrote on his social media platform Truth Social- For many years, the world is surprised by these things why the drugs of other countries in America are so high. Some medicines are five to ten times more expensive, while the same laboratory or plant has been prepared by the same company.
Pharma shares fell from Trump’s announcement
Trump accused the pharmaceutical companies of discrimination on research and development expenses, saying that American consumers were put unnecessary burden for unnecessary years.
Similarly, shares of pharma companies saw a decline in the entire Asian market. Shares of drug manufacturers from South Korea and Japan were also seen slipping. During the Tokyo Trade, the pharmaceutical pharmaceutical pharmaceutical has come down by 7.2 percent, which is the fastest decline in this month.
Whereas, shares of Daiichi Sankyo and Takeda pharmaceutical companies fell down by 5 percent. South Korea’s SK Biofarmasuticals, CellTrion and Samsung Biologics shares also saw a decline of 3 per cent.